益佰制药
(600594)
| 流通市值：34.45亿 | | | 总市值：34.45亿 |
| 流通股本：7.92亿 | | | 总股本：7.92亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 695,146,756.66 | 457,074,557.37 | 521,007,309.87 | 619,878,982.72 |
| 应收票据及应收账款 | 410,986,471.31 | 537,542,735.57 | 528,936,121.87 | 492,605,525.89 |
| 其中：应收票据 | 220,189,595.8 | 303,725,854.59 | 337,574,641.63 | 252,850,526.87 |
| 应收账款 | 190,796,875.51 | 233,816,880.98 | 191,361,480.24 | 239,754,999.02 |
| 预付款项 | 22,412,623.41 | 20,093,259.89 | 13,747,641.74 | 16,376,625.3 |
| 其他应收款合计 | 21,140,407.32 | 21,263,944.52 | 19,229,782.13 | 26,764,565.86 |
| 存货 | 571,511,212.81 | 592,276,091.04 | 607,774,905.96 | 552,834,263.39 |
| 其他流动资产 | 57,371,202.87 | 57,038,076.99 | 59,330,333.32 | 24,157,134.13 |
| 流动资产合计 | 1,778,568,674.38 | 1,685,288,665.38 | 1,750,026,094.89 | 1,732,617,097.29 |
| 非流动资产: | | | | |
| 长期股权投资 | 34,588,846.78 | 34,975,402.53 | 35,101,388.03 | 35,220,246.41 |
| 其他权益工具投资 | 1,330,862.51 | 1,312,880.51 | 1,312,880.51 | 1,630,909.7 |
| 固定资产 | 1,533,935,870.96 | 1,568,043,725.42 | 1,602,546,475.65 | 1,602,010,050.71 |
| 在建工程 | 4,472,266.08 | 6,964,634.08 | 699,426.57 | 5,467,637.29 |
| 生产性生物资产 | 15,510,435.52 | 15,403,025.54 | 15,286,302.46 | 15,906,704 |
| 使用权资产 | 25,775,467.96 | 27,646,672.72 | 29,517,877.48 | 31,842,916.24 |
| 无形资产 | 315,187,760.09 | 315,596,640.85 | 319,558,174.21 | 319,018,931.35 |
| 商誉 | 131,262,741.12 | 131,262,741.12 | 131,262,741.12 | 164,038,070.15 |
| 长期待摊费用 | 94,830,295.71 | 97,565,779.33 | 103,469,961.57 | 106,949,892.75 |
| 递延所得税资产 | 98,582,418.15 | 93,368,355.23 | 90,342,190.82 | 85,088,599.9 |
| 其他非流动资产 | 18,275,899.22 | 17,474,286.02 | 20,577,728.17 | 67,366,435.25 |
| 非流动资产合计 | 2,273,752,864.1 | 2,309,614,143.35 | 2,349,675,146.59 | 2,434,540,393.75 |
| 资产总计 | 4,052,321,538.48 | 3,994,902,808.73 | 4,099,701,241.48 | 4,167,157,491.04 |
| 流动负债: | | | | |
| 短期借款 | 510,911,907.83 | 405,952,683.38 | 380,928,986.1 | 290,825,916.68 |
| 应付票据及应付账款 | 100,722,423.99 | 113,928,580.08 | 124,483,297.23 | 127,423,809.2 |
| 应付账款 | 100,722,423.99 | 113,928,580.08 | 124,483,297.23 | 127,423,809.2 |
| 合同负债 | 35,630,377.56 | 24,459,061.8 | 27,124,413.57 | 25,370,790.73 |
| 应付职工薪酬 | 31,644,724.43 | 29,302,135.76 | 45,575,128.4 | 40,554,697.28 |
| 应交税费 | 24,794,489.61 | 29,494,935.43 | 22,236,961.61 | 37,128,104.93 |
| 其他应付款合计 | 82,074,892.37 | 94,935,200.83 | 109,773,639.89 | 73,306,028.71 |
| 其中:应付利息 | 171,203.52 | 171,203.52 | 171,203.52 | 171,203.52 |
| 一年内到期的非流动负债 | 202,419,148.74 | 213,498,894.45 | 235,089,377.73 | 268,667,309.17 |
| 其他流动负债 | 2,617,914.27 | 2,773,583.14 | 3,800,686.87 | 3,940,001.77 |
| 流动负债合计 | 990,815,878.8 | 914,345,074.87 | 949,012,491.4 | 867,216,658.47 |
| 非流动负债: | | | | |
| 长期借款 | 249,986,836.78 | 249,996,836.78 | 307,516,836.78 | 280,795,670.61 |
| 租赁负债 | 20,570,171.89 | 20,774,033.99 | 22,905,549.85 | 24,356,497.53 |
| 长期应付款 | 80,000,000 | 83,466,815.74 | 83,877,534.76 | 84,713,594.73 |
| 预计负债 | 189,875.48 | 307,540.05 | 899,991.93 | 271,290.7 |
| 递延收益 | 93,514,674.25 | 97,298,517.81 | 94,639,954.63 | 97,986,937.93 |
| 递延所得税负债 | 33,478,217.51 | 34,031,525.57 | 34,738,580.68 | 35,041,209.08 |
| 非流动负债合计 | 477,739,775.91 | 485,875,269.94 | 544,578,448.63 | 523,165,200.58 |
| 负债合计 | 1,468,555,654.71 | 1,400,220,344.81 | 1,493,590,940.03 | 1,390,381,859.05 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 791,927,400 | 791,927,400 | 791,927,400 | 791,927,400 |
| 资本公积 | 653,836,676.92 | 653,836,676.92 | 653,836,676.92 | 653,836,676.92 |
| 减:库存股 | 25,004,481.14 | 25,004,481.14 | 25,004,481.14 | 14,997,308 |
| 其他综合收益 | 459,752.34 | 446,265.84 | 446,265.84 | 672,255.73 |
| 盈余公积 | 314,569,579.33 | 314,569,579.33 | 314,569,579.33 | 314,569,579.33 |
| 未分配利润 | 734,080,957.95 | 744,597,296.08 | 753,983,015.54 | 902,047,094.34 |
| 归属于母公司股东权益合计 | 2,469,869,885.4 | 2,480,372,737.03 | 2,489,758,456.49 | 2,648,055,698.32 |
| 少数股东权益 | 113,895,998.37 | 114,309,726.89 | 116,351,844.96 | 128,719,933.67 |
| 股东权益合计 | 2,583,765,883.77 | 2,594,682,463.92 | 2,606,110,301.45 | 2,776,775,631.99 |
| 负债和股东权益合计 | 4,052,321,538.48 | 3,994,902,808.73 | 4,099,701,241.48 | 4,167,157,491.04 |
| 公告日期 | 2025-08-21 | 2025-04-26 | 2025-04-26 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |